THE SAGE GROUP Supports the “STOP P.A.D.” Petition Drive to Expand Medicare Coverage to Test patients for peripheral Arterial Disease. September 15, 2009

THE SAGE GROUP Reports that in 2007 Approximately 2.8 million people in Western Europe Suffered from Critical Limb Ischemia. October 20, 2008

THE SAGE GROUP Reports that in 2007 Between 4 and 8.4 Million Europeans Suffered from the Symptoms of Intermittent Claudication. February 28, 2008

THE SAGE GROUP Finds a Significant Number of New Pharmaceuticals in Clinical Trials for Treatment of Peripheral Arterial Disease. February 13, 2008

THE SAGE GROUP Reports that in 2006 Approximately 2 Million People in the United States Suffered from Critical Limb Ischemia. April 17, 2007

THE SAGE GROUP Commends the Launch of the National Peripheral Arterial Disease Awareness Campaign “Stay in Circulation: Take Steps to Learn About P.A.D.” September 20, 2006

THE SAGE GROUP Reports that the Acute Limb Ischemia (ALI) Market is Approximately $800 Million to $1.2 Billion. September 21, 2005

Peripheral Arterial Disease (PAD)-Related Amputations Cost an Estimated $10 Billion, According to THE SAGE GROUP. September 9, 2004

Peripheral Arterial Disease Represents a Significant and Rapidly Growing Market Opportunity for Interventional Therapies, Particularly Endovascular Technologies. August 25, 2004

Peripheral Arterial Disease Seen as a Major New Market for Drug and Interventional Therapies, According to an Analysis Published by THE SAGE GROUP. May 21, 2003